BBVA
SLNO

Banco Bilbao Vizcaya Argentaria’s Soleno Therapeutics SLNO Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,333
Closed -$111K – 744
2020
Q2 		$111K Hold
3,333
– – ﹤0.01% 738
2020
Q1 		$119K Hold
3,333
– – ﹤0.01% 648
2019
Q4 		$134K Buy
+3,333
New +$85.3K ﹤0.01% 695

Other funds holding SLNO

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's SLNO Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Soleno Therapeutics (SLNO) in Q3 2020, closing a stake of 3,333 shares — an estimated $111K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in SLNO in Q4 2019 and held it in 3 quarters. The position peaked at $134K in Q4 2019. 66 funds tracked by Wall St. Rank hold SLNO as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Soleno Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 3,333 Soleno Therapeutics shares in Q3 2020, an estimated $111K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Soleno Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Soleno Therapeutics position peaked at $134K in Q4 2019.
  • 66 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.